Midaflur (
INN; EXP 338) is an extremely stable
3-imidazoline derivative with central skeletal muscle relaxant and
sedative properties in humans[1] and other species of mammals, exhibiting consistently high oral bioavailability and a long duration of action. While its
pharmacodynamics remain poorly understood, midaflur resembles
meprobamate and
pentobarbital in terms of observed effects while being considerably more potent.[2]